July 16, 2021

Duopharma Biotech Granted Conditional Registration Approval for COVID 19 Sinopharm Vaccine

KUALA LUMPUR, 16 July 2021 – Duopharma (M) Sendirian Berhad, a wholly-owned
subsidiary of Duopharma Biotech Berhad (“Duopharma Biotech”), has been granted

conditional registration approval by Malaysia’s Drug Control Authority (“DCA”) for the Covid-
19 Sinopharm vaccine developed by China National Biotec Group Company Limited

(“Sinopharm CNBG”).